Table 3.
Admission clinical and laboratory findings according to outcome.
| Good functional outcome (mRS ≤ 2) (n = 637) | Poor functional outcome (mRS > 2) (n = 85) | P | |
|---|---|---|---|
| Systolic blood pressure (mmHg) | 157.4 ± 25.0 | 156.7 ± 22.0 | 0.813 |
| Diastolic blood pressure (mmHg) | 83.2 ± 13.8 | 83.8 ± 15.1 | 0.724 |
| Baseline NIHSS scores (median, IQR) | 2.0 (1–3) | 10 (7–13) | 0.000 |
| TSH (IU/L) (median, IQR) | 1.6 (1.06–2.27) | 1.56 (1.06–2.12) | 0.429 |
| Total T3 (ng/mL) (median, IQR) | 0.84 (0.74–0.95) | 0.79 (0.63–0.89) | 0.001 |
| Total T4 (µg/dL) (median, IQR) | 6.48 (5.74–7.42) | 7.13 (6.08–8.07) | 0.001 |
| Free T3 (pg/mL) (median, IQR) | 2.54 (2.29–2.85) | 2.39 (2.12–2.66) | 0.000 |
| Free T4 (ng/dL) (median, IQR) | 1.08 (0.99–1.19) | 1.13 (1.03–1.26) | 0.001 |
| Free T3/free T4 (median, IQR) | 2.36 (2.08–2.68) | 2.08 (1.85–2.37) | 0.000 |
| Initial WBC count (×109/L) (median, IQR) | 6.8 (5.6–8.6) | 7.9 (6.3–9.3) | 0.722 |
| Glucose on admission (mmol/L) (median, IQR) | 7.0 (5.8–9.3) | 7.6 (6.0–11.4) | 0.122 |
| C-reactive protein (mg/dL) (median, IQR) | 1.8 (0.9–4.1) | 2.4 (1.0–4.7) | 0.025 |
mRS, modified Rankin Scale; IQR, interquartile range; TSH, thyroid-stimulating hormone; T3, triiodothyronine; T4, thyroxine; WBC, white blood cell.